Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report

Gene alteration in anaplastic lymphoma kinase (ALK) is rare, and the efficacy of ALK inhibitors in the treatment of carcinoma of unknown primary (CUP) with ALK alteration remains unclear. The patient was a 56-year-old woman who presented with cervical lymph node swelling. Computed tomography reveale...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Curr Oncol
Egile Nagusiak: Sugiyama, Keiji, Izumika, Ai, Iwakoshi, Akari, Nishibori, Riko, Sato, Mariko, Shiraishi, Kazuhiro, Hattori, Hiroyoshi, Nishimura, Rieko, Kitagawa, Chiyoe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161847/
https://ncbi.nlm.nih.gov/pubmed/34064158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28030180
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak